Glucotrack (GCTK) FCF Margin (2014 - 2020)
Glucotrack's (GCTK) quarterly FCF Margin came in at 930927.84% in Q2 2020, down 92982073.0% on a YoY basis from N/an in Q3 2019, and down 1915.77% quarter-over-quarter from 46182.15% in Q1 2020.
Analysis
Glucotrack (GCTK) FCF Margin (2014 - 2020) Analysis & Trends
Glucotrack (GCTK) has reported FCF Margin for 7 consecutive years, with 930927.84% the latest figure, recorded in Q2 2020.
- For the quarter ending Q2 2020, FCF Margin fell 92982073.0% year-over-year to 930927.84%; the trailing twelve-month figure through Sep 2020 stood at 4998.77% (down 199228.0% YoY), and the FY2019 full-year result was 1885.58%, up 937649.0% from the prior year.
- FCF Margin retreated to 930927.84% in Q2 2020 per GCTK's latest filing, from 46182.15% in the prior quarter.
- Across five years, FCF Margin topped out at 169.98% in Q4 2017 and bottomed at 930927.84% in Q2 2020.
- Historically, FCF Margin has averaged 71415.49% across 5 years, with a median of 5061.5% in 2018.
- The sharpest annual moves came in 2018 and 2020: FCF Margin surged 2151925 bps in 2018, then sank 92982073 bps in 2020.
- Over 5 years, FCF Margin stood at 13169.25% in 2016, then surged by 99 bps to 169.98% in 2017, then slumped by 3813 bps to 6651.76% in 2018, then jumped by 82 bps to 1176.38% in 2019, then sank by 79035 bps to 930927.84% in 2020.
- According to Business Quant data, FCF Margin over the past three periods registered 930927.84%, 46182.15%, and 1176.38% for Q2 2020, Q1 2020, and Q4 2019 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.35 Bn | 175.75 Bn | 7.27 Bn | 15.81% |
| 2 | Intuitive Surgical | 127.64 Bn | 122.42 Bn | 1.96 Bn | 32.79% |
| 3 | Medtronic | 117.17 Bn | 108.35 Bn | 6.34 Bn | 13.22% |
| 4 | Stryker | 105.09 Bn | 101.62 Bn | 4.50 Bn | 16.07% |
| 5 | Boston Scientific | 64.76 Bn | 64.22 Bn | 3.85 Bn | 23.50% |
| 6 | Edwards Lifesciences | 49.91 Bn | 45.66 Bn | 1.35 Bn | 33.60% |
| 7 | Alcon | 33.09 Bn | 31.64 Bn | 1.68 Bn | 21.78% |
| 8 | Dexcom | 32.24 Bn | 30.29 Bn | 830.00 Mn | 14.10% |
| 9 | Steris | 20.78 Bn | 20.30 Bn | 684.20 Mn | 18.73% |
| 10 | Glucotrack | 1.06 Mn | -68,752.73 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | -930,927.84% |
| Mar 31, 2020 | -46,182.15% |
| Dec 31, 2019 | -1,176.38% |
| Sep 30, 2019 | -25,727.09% |
| Jun 30, 2019 | -1,107.11% |
| Mar 31, 2019 | -3,236.84% |
| Jun 30, 2018 | -6,651.76% |
| Mar 31, 2018 | -5,061.50% |
| Dec 31, 2017 | -169.98% |
| Sep 30, 2017 | -7,251.74% |
| Jun 30, 2017 | -28,171.01% |
| Mar 31, 2017 | -1,192.46% |
| Sep 30, 2016 | -13,169.25% |
| Jun 30, 2016 | -634.80% |
| Mar 31, 2016 | -572.47% |
| Jun 30, 2015 | -1,852.72% |
| Mar 31, 2015 | -801.21% |
| Sep 30, 2014 | -3,175.91% |